News & Events

• September 30, 2021
  

  C-Path and Pulse Infoframe Establish Patient-Centered Data Harmonization Partnership to Accelerate Collaborative Research in Rare Disease

  Critical Path Institute (C-Path) and Pulse Infoframe announced today their collaboration to advance technologies and tools to further rare disease research and drug development. In addition, both organizations will support the creation of more streamlined and transparent informed consent processes and best practices for the development of global unique identifiers, data standards and data dictionaries.

• September 15, 2021
  

  Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program

  The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP^®) officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation. The launch was part of an all-day virtual workshop and annual meeting of rare disease stakeholders, featuring a platform demonstration, industry expert presentations and attendance by over 400 patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists.

• July 15, 2021
  

  Launch of UNITE4TB Partnership Marks a New Era in Tuberculosis Treatment Development

  To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched. The 7-year, €185 million project called UNITE4TB, aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs, with the goal of developing new and highly active TB treatment regimens for drug-resistant and -sensitive TB.

• April 26, 2021
  

  C-Path Selects New Leaders of Data Science and Quantitative Medicine

  TUCSON, Ariz., April 26, 2021 — Critical Path Institute (C-Path) has named Amanda J. Borens, M.S., as Executive Director of Data Science within C-Path’s Data Collaboration Center (DCC), and Jackson Burton, Ph.D., as Executive Director of C-Path’s Quantitative Medicine Program. Amanda Borens, MSc Executive Director of Data Science Borens has been with C-Path for nearly......
• April 22, 2021
  

  C-Path Opens Access to Duchenne Regulatory Science Consortium Database

  Database will allow sharing of individual-level data with the goal of accelerating therapy development for Duchenne muscular dystrophy TUCSON, Ariz., April 22, 2021 — Critical Path Institute (C-Path) announced today that it will open access to the Duchenne Regulatory Science Consortium (D-RSC) database to qualified researchers, through its Rare Disease Cures Accelerator, Data and Analytics......